← Back to Search

Light Therapy

LED Light Therapy for Alopecia

N/A
Waitlist Available
Led By Amy McMichael, M.D.
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women who are between the age of eighteen years and sixty-five years
Biopsy-proven diagnosis of CCCA Stage II-IV.
Must not have
Subjects with other forms of hair loss that is not CCCA
Prior treatment with light source for alopecia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, month 2, month 4, month 6
Awards & highlights
No Placebo-Only Group

Summary

This trial will examine if a cap w/LED light can stop hair loss & regrow hair in people w/Central centrifugal cicatricial alopecia. Participants will use the cap once daily for 10 mins.

Who is the study for?
This trial is for women aged 18-65 with a biopsy-proven diagnosis of Central centrifugal cicatricial alopecia (CCCA) stages II-IV. Participants must have been on stable treatment, such as doxycycline or minoxidil, without changes for at least 3 months. Men and those with other forms of hair loss are excluded.
What is being tested?
The study tests the Revian Red All LED cap's effectiveness in treating CCCA by promoting hair growth or reducing inflammation. Participants will use the LED cap daily for a 10-minute session to see if it stops hair loss and encourages regrowth.
What are the potential side effects?
Potential side effects are not explicitly mentioned but may include scalp irritation due to light exposure from the LED cap. Since this is a non-invasive treatment, severe side effects are unlikely.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman aged between 18 and 65.
Select...
My condition is confirmed as CCCA Stage II-IV through a biopsy.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My hair loss is not due to CCCA.
Select...
I have been treated with light therapy for hair loss.
Select...
I am not a male, as males are not eligible for this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, month 2, month 4, month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 2, month 4, month 6 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Shape of the hairline documented with photographs
Secondary study objectives
Change in Breakage Assessments of hairline change by study physician
Change in Erythema Assessments of hairline change by study physician
Change in Hyperpigmentation Assessments of hairline change by study physician
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Using the Revian Red All LED cap 10 minutes each day for 6 months

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,403 Previous Clinical Trials
2,477,835 Total Patients Enrolled
Amy McMichael, M.D.Principal InvestigatorWake Forest University Health Sciences

Media Library

Revian Red All LED Cap (Light Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05759338 — N/A
Central Centrifugal Alopecia Research Study Groups: Intervention
Central Centrifugal Alopecia Clinical Trial 2023: Revian Red All LED Cap Highlights & Side Effects. Trial Name: NCT05759338 — N/A
Revian Red All LED Cap (Light Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05759338 — N/A
~29 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top